Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes

被引：0
作者：
Robert Krysiak
Boguslaw Okopień
Zbigniew S. Herman
机构：
[1] Medical University of Silesia,Department of Clinical Pharmacology
来源：
Drugs | 2003年 / 63卷
关键词：
Simvastatin; Atorvastatin; Pravastatin; Human Umbilical Vein Endothelial Cell; Tissue Factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent large clinical trials have demonstrated that HMG-CoA reductase inhibitors, or statins, markedly reduce morbidity and mortality when used in the primary and secondary prevention of cardiovascular disease. It has been established that the benefits of statin therapy in cardiovascular disease can be explained not only by the lipid-lowering potential of statins but also by nonlipid-related mechanisms (so-called ‘pleiotropic effects’) that contribute to the positive effect of statins on the incidence of cardiovascular events.
引用
收藏
页码：1821 / 1854
页数：33
相关论文
共 419 条
[91]  
Gottsater A(2001)Effect of an estrogen/statin combination on biochemical markers of endothelial function in human coronary artery cell cultures Menopause 8 216-8
[92]  
Anwaar I(2002)Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering Arterioscler Thromb Vasc Biol 22 692-6
[93]  
Lind P(1997)Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia [letter] Lancet 350 1222-7
[94]  
Tan K(2000)Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients Transplantation 69 1830-85
[95]  
Janus ED(2002)Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study Thromb Haemost 88 41-403
[96]  
Lam KS(1995)Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia Arterioscler Thromb Vasc Biol 15 879-65
[97]  
Cortellaro M(1997)Fluvastatin and tissue factor pathway inhibitor in type IIA and IIB hyperlipidemia and in acute myocardial infarction Thromb Res 87 397-12
[98]  
Cofrancesco E(2000)Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia Arterioscler Thromb Vasc Biol 20 259-54
[99]  
Boschetti C(2001)Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients Atherosclerosis 154 203-402
[100]  
Lin TH(2001)Diabetes mellitus: a hypercoagulable state J Diabetes Complications 15 44-6
567891011121314